Although METTL14 was reported to be an independent prognostic factor for ccRCC [24], combining METTL14 with m6A-modified genes could have better diagnostic and prognostic potential than using METTL14 alone. The gene discussed is METTL14; the disease is nonpapillary renal cell carcinoma.